Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants

Brain. 2023 Oct 3;146(10):e75-e76. doi: 10.1093/brain/awad177.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Humans
  • Neoplasms*